- You have no items in your shopping cart
- Subtotal: $0.00
Fatima
Posted on
PSMA PET and treatment intensification in mHSPC
Source: Urology Times
“The main challenge at the moment is patients are being diagnosed with metastatic disease far earlier than they would have been otherwise, and therefore [are being] considered for combination systemic therapy potentially years earlier than they would have been if we just looked at conventional imaging," says Dr Louise Kostos.
In a recent study in European Urology, investigators sought to review data regarding combination therapies for the treatment of locally advanced and metastatic hormone-sensitive prostate cancer.1 In their paper, the authors touched on the integration… [1841 chars]